Skip to main content

12.12.2023 | original article

MELD-Na score is associated with postoperative complications in non-cirrhotic gastric cancer patients undergoing gastrectomy

verfasst von: Omer Akay, M.D, Mert Guler, M.D, Husnu Sevik, M.D, Ishak Yildiz, M.D, Prof. Mert Mahsuni Sevinc, M.D, Assoc. Prof. Aziz Ari, M.D, Assoc. Prof. Ufuk Oguz Idiz, M.D, Assoc. Prof. Cihad Tatar, M.D.

Erschienen in: European Surgery

Einloggen, um Zugang zu erhalten

Summary

Background

We aimed to investigate whether the MELD-Na score has a predictive value for postoperative complications in non-cirrhotic gastric cancer patients undergoing gastrectomy.

Materials and methods

The non-cirrhotic patients who were diagnosed with gastric cancer and underwent gastrectomy in our center from December 2020 to June 2022 were enrolled. MELD-Na scores of all patients were calculated within 48 h before surgery. A cut-off value was calculated for the MELD-Na score and patients were divided into two groups with a score of ≤ 10 and > 10. Postoperative 30-day complications including bleeding, ileus, wound infection, intra-abdominal abscess, evisceration, obstruction, anastomosis leakage, and pulmonary and cardiac complications were recorded. Clavien–Dindo scores were calculated. Univariate and multivariate analyses were performed.

Results

A total of 159 patients were included in this study. In the patients with a score of more than 10, wound infection, postoperative bleeding, pulmonary complications, re-operation risk, and any complications were found to increase significantly. A positive correlation was found between the Clavien–Dindo score and the higher value of MELD-Na score (p = 0.046). Moreover, postoperative complications were significantly higher in patients with comorbidity and high pathologic stages (p = 0.002 and 0.044, respectively). Multivariate analysis showed that comorbidity and high MELD-Na score were independent risk factors for postoperative complications.

Conclusion

In this study, it was found that a higher value of MELD-Na score was an independent predictive factor for development of postoperative complications.
Literatur
1.
Zurück zum Zitat Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet. 1996;347:995–9.CrossRefPubMed Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet. 1996;347:995–9.CrossRefPubMed
2.
Zurück zum Zitat Li QG, Li P, Tang D, Chen J, Wang DR. Impact of postoperative complications on long-term survival after radical resection for gastric cancer. World J Gastroenterol. 2013;19(25):4060–5.CrossRefPubMedPubMedCentral Li QG, Li P, Tang D, Chen J, Wang DR. Impact of postoperative complications on long-term survival after radical resection for gastric cancer. World J Gastroenterol. 2013;19(25):4060–5.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Chen K, Mou YP, Xu XW, Cai JQ, Wu D, Pan Y, Zhang R‑C. Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer. BMC Gastroenterol. 2014;14(1):41.CrossRefPubMedPubMedCentral Chen K, Mou YP, Xu XW, Cai JQ, Wu D, Pan Y, Zhang R‑C. Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer. BMC Gastroenterol. 2014;14(1):41.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Japan clinical oncology group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.CrossRefPubMed Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Japan clinical oncology group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.CrossRefPubMed
5.
Zurück zum Zitat Zhang J, Jiang L, Zhu X. A novel nomogram for prediction of early postoperative complications of total gastrectomy for gastric cancer. Cancer Manag Res. 2021;13:7579–91.CrossRefPubMedPubMedCentral Zhang J, Jiang L, Zhu X. A novel nomogram for prediction of early postoperative complications of total gastrectomy for gastric cancer. Cancer Manag Res. 2021;13:7579–91.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kassir R, Blanc P, Tibalbo LMB, Breton C, Lointier P. C‑Reactive protein and procalcitonin for the early detection of postoperative complications after sleeve gastrectomy: preliminary study in 97 patients. Surg Endosc. 2015;29:1439–44.CrossRefPubMed Kassir R, Blanc P, Tibalbo LMB, Breton C, Lointier P. C‑Reactive protein and procalcitonin for the early detection of postoperative complications after sleeve gastrectomy: preliminary study in 97 patients. Surg Endosc. 2015;29:1439–44.CrossRefPubMed
9.
Zurück zum Zitat Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.CrossRefPubMed Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.CrossRefPubMed
11.
Zurück zum Zitat Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the atherosclerosis risk in communities study. Arterioscler Thromb Vasc Biol. 2014;34:1770–7.CrossRefPubMedPubMedCentral Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the atherosclerosis risk in communities study. Arterioscler Thromb Vasc Biol. 2014;34:1770–7.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lin JP, O’Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham heart study. Circulation. 2006;114:1476–81.CrossRefPubMed Lin JP, O’Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham heart study. Circulation. 2006;114:1476–81.CrossRefPubMed
13.
Zurück zum Zitat Lange EO, Jensen CC, Melton GB, Madoff RD, Kwaan MR. Relationship between model for end-stage liver disease score and 30-day outcomes for patients undergoing elective colorectal resections: an American college of surgeons-national surgical quality improvement program study. Dis Colon Rectum. 2015;58:494–501.CrossRefPubMed Lange EO, Jensen CC, Melton GB, Madoff RD, Kwaan MR. Relationship between model for end-stage liver disease score and 30-day outcomes for patients undergoing elective colorectal resections: an American college of surgeons-national surgical quality improvement program study. Dis Colon Rectum. 2015;58:494–501.CrossRefPubMed
14.
Zurück zum Zitat Hedrick TL, Swenson BR, Friel CM. Model for end-stage liver disease (MELD) in predicting postoperative mortality of patients undergoing colorectal surgery. Am Surg. 2013;79:347–52.CrossRefPubMed Hedrick TL, Swenson BR, Friel CM. Model for end-stage liver disease (MELD) in predicting postoperative mortality of patients undergoing colorectal surgery. Am Surg. 2013;79:347–52.CrossRefPubMed
15.
Zurück zum Zitat Al Abbas AI, Borrebach JD, Bellon J, Zureikat AH. Does preoperative MELD score predict adverse outcomes following pancreatic resection: an ACS NSQIP analysis. J Gastrointest Surg. 2020;24:2259–68.CrossRefPubMed Al Abbas AI, Borrebach JD, Bellon J, Zureikat AH. Does preoperative MELD score predict adverse outcomes following pancreatic resection: an ACS NSQIP analysis. J Gastrointest Surg. 2020;24:2259–68.CrossRefPubMed
16.
Zurück zum Zitat Coakley KM, Sarasani S, Prasad T, Steele SR, Paquette I, Heniford BT, Bradley R, Davis BR. MELD-Na score as a predictor of anastomotic leak in elective colorectal surgery. J Surg Res. 2018;232:43–8.CrossRefPubMed Coakley KM, Sarasani S, Prasad T, Steele SR, Paquette I, Heniford BT, Bradley R, Davis BR. MELD-Na score as a predictor of anastomotic leak in elective colorectal surgery. J Surg Res. 2018;232:43–8.CrossRefPubMed
18.
Zurück zum Zitat Zielsdorf SM, Kubasiak JC, Janssen I, Myers JA, Luu MB. A NSQIP analysis of MELD and perioperative outcomes in general surgery. Am Surg. 2015;81(8):755–9.CrossRefPubMed Zielsdorf SM, Kubasiak JC, Janssen I, Myers JA, Luu MB. A NSQIP analysis of MELD and perioperative outcomes in general surgery. Am Surg. 2015;81(8):755–9.CrossRefPubMed
19.
Zurück zum Zitat Rudasill SE, Dipardo B, Sanaiha Y, Mardock AL, Cale M, Antonios JW, Khoury H, Benharash P. International normalized ratio (INR) is comparable to MELD in predicting mortality after cholecystectomy. Am Surg. 2019;85(10):1184–8.CrossRefPubMed Rudasill SE, Dipardo B, Sanaiha Y, Mardock AL, Cale M, Antonios JW, Khoury H, Benharash P. International normalized ratio (INR) is comparable to MELD in predicting mortality after cholecystectomy. Am Surg. 2019;85(10):1184–8.CrossRefPubMed
20.
Zurück zum Zitat Causey MW, Steele SR, Farris Z, Lyle DS, Beitler AL. An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery. Am J Surg. 2012;203:589–93.CrossRefPubMed Causey MW, Steele SR, Farris Z, Lyle DS, Beitler AL. An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery. Am J Surg. 2012;203:589–93.CrossRefPubMed
21.
Zurück zum Zitat Causey MW, Nelson D, Johnson EK, Maykel J, Davis B, Rivadeneira DE, Champagne B, Steele SR. The impact of model for end-stage liver disease-na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease. Am J Surg. 2014;207(4):520–6.CrossRefPubMed Causey MW, Nelson D, Johnson EK, Maykel J, Davis B, Rivadeneira DE, Champagne B, Steele SR. The impact of model for end-stage liver disease-na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease. Am J Surg. 2014;207(4):520–6.CrossRefPubMed
22.
Zurück zum Zitat Schlosser KA, Kao AM, Zhang Y, Prasad T, Kasten KR, Davis BR, Heniford BT, Colavita PD. MELD-Na score associated with postoperative complications in hernia repair in non-cirrhotic patients. Hernia. 2019;23(1):51–9.CrossRefPubMed Schlosser KA, Kao AM, Zhang Y, Prasad T, Kasten KR, Davis BR, Heniford BT, Colavita PD. MELD-Na score associated with postoperative complications in hernia repair in non-cirrhotic patients. Hernia. 2019;23(1):51–9.CrossRefPubMed
24.
Zurück zum Zitat Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P, Vanella S. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: a retrospective cohort study. World J Gastroenterol. 2022;28(3):381–98.CrossRefPubMedPubMedCentral Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P, Vanella S. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: a retrospective cohort study. World J Gastroenterol. 2022;28(3):381–98.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Tsekrekos A, Lovece A, Chrysikos D, Ndegwa N, Schizas D, Kumagai K, Rouvelas L. Impact of obesity on the outcomes after gastrectomy for gastric canser. Asian J Surg. 2022;45(1):15–26.CrossRefPubMed Tsekrekos A, Lovece A, Chrysikos D, Ndegwa N, Schizas D, Kumagai K, Rouvelas L. Impact of obesity on the outcomes after gastrectomy for gastric canser. Asian J Surg. 2022;45(1):15–26.CrossRefPubMed
Metadaten
Titel
MELD-Na score is associated with postoperative complications in non-cirrhotic gastric cancer patients undergoing gastrectomy
verfasst von
Omer Akay, M.D
Mert Guler, M.D
Husnu Sevik, M.D
Ishak Yildiz, M.D
Prof. Mert Mahsuni Sevinc, M.D
Assoc. Prof. Aziz Ari, M.D
Assoc. Prof. Ufuk Oguz Idiz, M.D
Assoc. Prof. Cihad Tatar, M.D.
Publikationsdatum
12.12.2023
Verlag
Springer Vienna
Erschienen in
European Surgery
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-023-00823-w